Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Wednesday 25 January, 2017

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 1314V
GlaxoSmithKline PLC
25 January 2017
 

GlaxoSmithKline plc (the 'Company')

 

Transaction notification

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr B McNamara

b)

Position/status

CEO, Consumer Healthcare

c)

Initial notification/

amendment

Initial Notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

American Depositary Shares ('ADSs')

 

ISIN: US37733W1053

 

b)

Nature of the transaction

The vesting of an award over 10,251 ADSs made under the GlaxoSmithKline Share Value Plan (SVP), granted to compensate for the value of awards forfeited on leaving Novartis, due to time pro-rating. Of the vested award, 3,926 ADSs were automatically withheld to meet tax liabilities. 

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

$38.72

10,251

 

 

 

 

 

d)

Aggregated information

n/a (single transaction)

Aggregated volume Price

 

e)

Date of the transaction

2017-01-23

f)

Place of the transaction

 

n/a

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHQELFLDFFFBBE

a d v e r t i s e m e n t